Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arianna Damiani

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Clinicoeconomics and Outcomes Research : CEOR|August 3, 2017
Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexateMaurizio Benucci, Roberto Ravasio, Arianna Damiani
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 5, 2023
Brain-Computer Interface to Deliver Individualized Multisensory Intervention for Neuropathic PainGiuseppe Valerio Aurucci, Greta Preatoni, Arianna Damiani, et al.
The Israel Medical Association Journal : IMAJ|March 10, 2020
The Nocebo Effect in Rheumatology: An Unexplored IssueFabrizio Cantini, Laura Niccoli, Giulia Franchi, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|May 2, 2020
Maurizio Benucci, Arianna Damiani, Maria Infantino, et al.
Joint Bone Spine|April 24, 2020
Old and new antirheumatic drugs for the treatment of COVID-19Maurizio Benucci, Arianna Damiani, Maria Infantino, et al.
Clinical and Experimental Rheumatology|August 17, 2024
Systemic sclerosis and environment: an intriguing and still debated associationGemma Lepri, Silvia Bellando Randone, Arianna Damiani, et al.
Expert Opinion on Drug Safety|December 23, 2021
Tailored first-line biologic and targeted synthetic disease modifying anti-rheumatic drugs therapy in patients with rheumatoid arthritis: 2021 updated ITABIO statementsFabrizio Cantini, Delia Goletti, Maurizio Benucci, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 27, 2019
Abatacept: from a budget impact model to cost-effectiveness analysis - data from RCT and real lifeMaurizio Benucci, Arianna Damiani, Mariangela Manfredi, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|September 3, 2025
Leveraging Functional and Structural Connectomics to Guide Neuromodulation in EpilepsyKetan Mehta, Arianna Damiani, Elvira Pirondini, et al.
Epilepsy Currents|March 16, 2026
Advances in Thalamic Neuromodulation for Epilepsy: From Mechanisms to Clinical TranslationJorge A Gonzalez-Martinez, Arianna Damiani, Joseph Parvizi, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Clinicoeconomics and Outcomes Research : CEOR|August 3, 2017
Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexateMaurizio Benucci, Roberto Ravasio, Arianna Damiani
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 5, 2023
Brain-Computer Interface to Deliver Individualized Multisensory Intervention for Neuropathic PainGiuseppe Valerio Aurucci, Greta Preatoni, Arianna Damiani, et al.
The Israel Medical Association Journal : IMAJ|March 10, 2020
The Nocebo Effect in Rheumatology: An Unexplored IssueFabrizio Cantini, Laura Niccoli, Giulia Franchi, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|May 2, 2020
Maurizio Benucci, Arianna Damiani, Maria Infantino, et al.
Joint Bone Spine|April 24, 2020
Old and new antirheumatic drugs for the treatment of COVID-19Maurizio Benucci, Arianna Damiani, Maria Infantino, et al.
Clinical and Experimental Rheumatology|August 17, 2024
Systemic sclerosis and environment: an intriguing and still debated associationGemma Lepri, Silvia Bellando Randone, Arianna Damiani, et al.
Expert Opinion on Drug Safety|December 23, 2021
Tailored first-line biologic and targeted synthetic disease modifying anti-rheumatic drugs therapy in patients with rheumatoid arthritis: 2021 updated ITABIO statementsFabrizio Cantini, Delia Goletti, Maurizio Benucci, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 27, 2019
Abatacept: from a budget impact model to cost-effectiveness analysis - data from RCT and real lifeMaurizio Benucci, Arianna Damiani, Mariangela Manfredi, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|September 3, 2025
Leveraging Functional and Structural Connectomics to Guide Neuromodulation in EpilepsyKetan Mehta, Arianna Damiani, Elvira Pirondini, et al.
Epilepsy Currents|March 16, 2026
Advances in Thalamic Neuromodulation for Epilepsy: From Mechanisms to Clinical TranslationJorge A Gonzalez-Martinez, Arianna Damiani, Joseph Parvizi, et al.
Pageof 7